Helicobacter pylori infection and liver diseases

Japanese Journal of Cancer and Chemotherapy

Volumn 38, Issue 3, 2011, Pages 362-365

  Takuma, Yoshitaka ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Helicobacter pylori; Hepatic encephalopathy; Liver diseases; Non alcoholic fatty liver diseases

Indexed keywords

ARTICLE; DISEASE ASSOCIATION; HELICOBACTER INFECTION; NONALCOHOLIC FATTY LIVER; RISK FACTOR;

EID: 79957964438     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fox JG, Yan L, Shames B, et al: Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 64: 3673-3681, 1996. (Pubitemid 26298692)
2. Fox JG, Yan L, Dewhirst FE, et al: Helicobacter bilis sp. nov., a novel Helicobacter isolated from bile, livers, and intestines of aged, inbred mouse strains. J Clin Microbiol 33: 445-454, 1995.
3. Matsukura N, Yokomuro S, Yamada S, et al: Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 93: 842-847, 2002.
4. Suto H, Azuma T, Ito S, et al: Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis. Gut 48: 605-608, 2001. (Pubitemid 32378577)
5. Ito S, Miyaji H, Azuma T, et al: Hyperammonaemia and Helicobacter pylori. Lancet 346: 124-125, 1995.
6. Miyaji H, Ito S, Azuma T, et al: Effect of Helicobacter pylori eradication therapy on hyperammonemia in patients with liver cirrhosis. Gut 40: 726-730, 1997. (Pubitemid 27305464)
7. Demirturk L, Yazgan Y, Zci O, et al: The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics. Helicobacter 6: 325-330, 2001. (Pubitemid 34015014)
8. Queiroz DM, Rocha AM, Rocha GA, et al: Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus. Dig Dis Sci 51: 370-373, 2006.
9. Shimamoto C, Hirata I and Katsu K: Breath and blood ammonia in liver cirrhosis. Hepatogastroenterology 47: 443-445, 2000. (Pubitemid 30216310)
10. Nandakumar R, Naik AS, Pandit B, et al: Effect of Helicobacter pylori eradication on serum ammonia levels in patients with chronic liver disease. Indian J Gastroenterol 22: 221-223, 2003. (Pubitemid 38282223)
11. Huber M, Rossle M, Siegerstetter V, et al: Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology 48: 541-544, 2001. (Pubitemid 32391607)
12. Calvet X, Nogueras C, Roque M, et al: Helicobacter pylori is not a risk factor for hepatic encephalopathy. Dig Liver Dis 33: 414-419, 2001. (Pubitemid 32677203)
13. Miquel J, Barcena R, Boixeda D, et al: Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy. Eur J Gastroenterol Hepatol 13: 1067-1072, 2001. (Pubitemid 32905200)
14. Nilsson HO, Taneera J, Castedal M, et al: Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 38: 1072-1076, 2000. (Pubitemid 30140562)
15. Vorobjova T, Nilsson I, Terjajev S, et al: Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection. Dig Liver Dis 38(3): 171-176, 2006.
16. Castéra L, Pedeboscq A, Rocha M, et al: Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liven a prospective study. World J Gastroenterol 12: 7278-7284, 2006. (Pubitemid 44911832)
17. Ito K, Nakamura M, Toda G, et al: Potential role of Helicobacter pylori in hepatocarcinogenesis. Int J Mol Med 13: 221-227, 2004.
18. Avenaud P, Marais A, Monteiro L, et al: Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 89: 1431-1439, 2000.
19. Xuan SY, Xin YN, Chen AJ, et al: Association between the presence of H pylori in the liver and hepatocellular carcinoma a meta-analysis. World J Gastroenterol 14: 307-312, 2008.
20. Angulo P: GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 25: 883-889, 2007.
21. Danesh J and Peto R: Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316: 1130-1132, 1998. (Pubitemid 28156459)
22. Gunji T, Matsuhashi N, Sato H, et al: Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 103: 3005-3010, 2008.
23. Gunji T, Matsuhashi N, Sato H, et al: Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 14: 144-150, 2009.
24. Nwokolo CU, Freshwater DA, O'Hare P, et al: Plasma ghrelin following cure of Helicobacter. Gut 52: 637-640, 2003. (Pubitemid 36528862)